Accessing Rare Disease Medications in India: What Patients Should Know

For patients living with rare diseases, the journey to diagnosis is often long and complex—but the search for appropriate treatment can be even more challenging. In India, where many rare disease treatments are not readily available, patients and caregivers often find themselves navigating a maze of uncertainty, regulations, and limited resources.

Bridging Drug Access Gaps: Named Patient Pathway

In an ideal world, every patient would have timely access to the medicines they need, regardless of where they live. But the reality is different. In many countries, including India, patients are often unable to access life-saving or life-enhancing treatments because those medicines are not yet approved, commercially launched, or available in the local market.

Ensuring Continuity in Clinical Trials: The Role of Strategic Drug Sourcing

In the highly regulated and fast-paced world of clinical research, ensuring continuity in clinical trials is paramount. Disruptions—whether due to drug shortages, supply chain breakdowns, or logistical delays—can derail timelines, inflate costs, and, most critically, put patient safety at risk.